WallStreetZenWallStreetZen

How to Buy Can Fite Biopharma Stock

Can Fite Biopharma Ltd

Can-Fite BioPharma Ltd. , a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction.

Can Fite Biopharma stock last closed at $2.26, up 3.67% from the previous day, and has decreased 1.74% in one year. It has overperformed other stocks in the Biotechnology industry by 0.04 percentage points. Can Fite Biopharma stock is currently +48.68% from its 52-week low of $1.52, and -32.13% from its 52-week high of $3.33.

As of Mar 27, 2024, there are 1.22B shares of CANF outstanding. The market cap of CANF is $8.30M. In the past 24 hours, 11,263 CANF shares were traded.

How to Buy Can Fite Biopharma Stock

Wondering how to invest in Can Fite Biopharma stock? Here's how.
  1. Decide where to buy Can Fite Biopharma stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Can Fite Biopharma stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit money your brokerage account: Pick your payment method and add your info.
  4. Research Can Fite Biopharma stock: The Can Fite Biopharma ticker symbol is CANF. Is Can Fite Biopharma stock a good investment? Should you buy shares of CANF? How do CANF's underlying business fundamentals look? Do top analysts think Can Fite Biopharma is a good buy? Why has CANF's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if CANF is a good stock to buy).
  5. Make your CANF trade: Decide if you will purchase CANF shares at the current market price or use a limit order to buy CANF shares at a given price.
  6. Get the latest news on your investment in CANF: Create a watchlist to important updates regarding your position in Can Fite Biopharma stock.

Step 1: Decide where to buy Can Fite Biopharma stock

You will need an online brokerage account to access the NYSEMKT market and buy CANF shares.

A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

In our opinion, eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Energy, New York to London — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've picked the right brokerage, the next step is to fill out some personal information so you can invest in CANF today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new brokerage account.
  1. Submit your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you have created your account on one of the best stock trading apps, you need to deposit funds:

Check out the walkthrough below for more details depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Can Fite Biopharma stock

Once you have identified the best place to buy Can Fite Biopharma stock, it's very important to research their stock before you buy, so you truly understand the risk as well as the opportunity.

Can Fite Biopharma stock at a glance

CANF Price
$2.26
1w %
1.35%
1y %
-1.74%
5y %
-98.18%
P/E
-0.75x
P/B
1.21x
P/S
11.41x
PEG
N/A
Revenue
$793.00k
Earnings
-$9.77M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$8.30M
Next Earnings
N/A
Next Dividend
N/A

Can Fite Biopharma Overview

WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on CANF's stock page.

Is CANF stock undervalued or overvalued?

You can use many financial metrics, analyses, models, and charts to gauge CANF's true value.

Using relative valuations metrics:

  • CANF could be undervalued based on its P/B ratio of 1.21x, relative to Biotechnology industry P/B ratio of 6.2x

You can do more valuation analysis on CANF's stock here.

CANF Financial Summary

Positive Financial Indicators:

  • CANF has $9.62M in cash and short term investments. This is sufficient to cover its annual cash burn of $9.77M.
  • Total CANF debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than long-term liabilities on the CANF balance sheet.
  • There are more short-term assets than short-term liabilities on the CANF balance sheet.

Negative Financial Indicators:

  • CANF profit margin has gone up by 1.74 percentage points in the past year, but the company is still unprofitable.
  • CANF has a relatively high debt to equity ratio of 0.61.
  • CANF has cash burn of 9774000. It does not have sufficient cash and short-term investments to cover this.

Is it a good time to buy CANF stock, according to Wall Street analysts?

Out of 1 sell side analysts who monitor CANF, the consensus analyst rating on Can Fite Biopharma is a Buy

Please note that analyst ratings are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are saying on the Can Fite Biopharma stock forecast page.

CANF Trading Indicators

SMA10
2.19
SMA20
2.18
SMA50
2.1
SMA100
2.1
SMA200
2.41
MACD
0.03
MACD Signal
0.03
MACD Histogram
0
RSI
58.8
Stochastic %K
78.55
Stochastic %D
77.51
StochRSI %K
29.7
StochRSI %D
28.89

CANF Performance Metrics

Last year, CANF revenue was $793.00k. In the past five year, CANF's revenue has increased by -12.6% per year. This was slower than the Biotechnology industry average of 29.77%.

Learn more about CANF's earnings and revenue performance here.

What are CANF insiders up to?

Over the past 12 months, insiders at CANF have not bought or sold any shares.

Research more about who owns CANF shares here.

Can I rely on CANF as an income stream?

No, Can Fite Biopharma doesn't provide an income stream by paying out dividends.

Get opinions from other traders

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your CANF trade

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at an exact price, use a limit order.

Hit the Open Trade button and your broker will execute the order.

If you need more help with buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get the latest news on your investment in CANF

Now that you own some CANF shares, you'll want to keep up with your new company.

Create a watchlist to keep track of your CANF stock.

CANF Feed

How to Buy Stock in Can Fite Biopharma

To summarize, here are the 6 steps you need to take to buy Can Fite Biopharma stock right now:

  1. Decide where to buy Can Fite Biopharma stock
  2. Open your brokerage account
  3. Deposit money your brokerage account
  4. Research Can Fite Biopharma stock
  5. Make your CANF trade
  6. Get the latest news on your investment in CANF

If you require a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to track your new investment in Can Fite Biopharma, create your watchlist below.

NYSEMKT: CANF
$2.26+0.08 (+3.67%)
Updated Mar 27, 2024
Open eToro Account
NYSEMKT: CANF
$2.26+0.08 (+3.67%)
Updated Mar 27, 2024
Open eToro Account

FAQ

How much does it cost to buy one Can Fite Biopharma share?

As of Mar 27, 2024, it costs $2.26 to buy one share of Can Fite Biopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.442 shares of CANF.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Can Fite Biopharma stock?

According to 1 Wall Street analysts who monitor Can Fite Biopharma, their consensus recommendation is to buy Can Fite Biopharma stock.

What is the best way to buy Can Fite Biopharma stock?

One way to place an order for Can Fite Biopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.